--- title: "EDAP TMS S.A. (EDAP.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/EDAP.US.md" symbol: "EDAP.US" name: "EDAP TMS S.A." industry: "Health Care Equipment" --- # EDAP TMS S.A. (EDAP.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Location | US Market | | Website | [focalone.com](https://focalone.com) | ## Company Profile EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ul... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-15T04:30:12.000Z **Overall: C (0.58)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 76 / 184 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.86% | | | Net Profit YoY | 9.28% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 6.38 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 174.62M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 71.27M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -59.52% | E | | Profit Margin | -30.77% | E | | Gross Margin | 43.02% | B | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 2.86% | C | | Net Profit YoY | 9.28% | C | | Total Assets YoY | -18.33% | E | | Net Assets YoY | -42.56% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -325.00% | D | | OCF YoY | 2.86% | C | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.91 | A | #### Debt Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 62.06% | D | ```chart-data:radar { "title": "Longbridge Financial Score - EDAP TMS S.A.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-59.52%", "rating": "E" }, { "name": "Profit Margin", "value": "-30.77%", "rating": "E" }, { "name": "Gross Margin", "value": "43.02%", "rating": "B" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "2.86%", "rating": "C" }, { "name": "Net Profit YoY", "value": "9.28%", "rating": "C" }, { "name": "Total Assets YoY", "value": "-18.33%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-42.56%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-325.00%", "rating": "D" }, { "name": "OCF YoY", "value": "2.86%", "rating": "C" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "0.91", "rating": "A" } ] }, { "name": "Security", "grade": "D", "indicators": [ { "name": "Gearing Ratio", "value": "62.06%", "rating": "D" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 04 | Stryker (US.SYK) | A | B | C | C | B | B | | 05 | Boston Scientific (US.BSX) | B | B | E | A | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -7.96 | 136/181 | - | - | - | | PB | 6.38 | 106/181 | 3.27 | 2.00 | 1.59 | | PS (TTM) | 2.45 | 63/181 | 1.46 | 1.18 | 0.88 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-01-16T05:00:00.000Z Total Analysts: **3** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 1 | 33% | | Overweight | 0 | 0% | | Hold | 2 | 67% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 4.67 | | Highest Target | 14.00 | | Lowest Target | 2.50 | ## References - [Company Overview](https://longbridge.com/en/quote/EDAP.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/EDAP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/EDAP.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.